Staff who provide data to the vaccine panel have been pushed aside, according to health officials, raising doubts about the ...

RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

Helen Chu, MD, urged doctors to find "science-based recommendations" from the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the American Academy of ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA ™ (clesrovimab-cfor), ...

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

Kennedy's picks circumvented the usual CDC process for selecting members of the Advisory Committee on Immunization Practices.

Rep Kim Schrier, MD, (D-Wash.), said on X yesterday that some of the newly appointed ACIP replacements are anti-vaccine ...

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...